135 related articles for article (PubMed ID: 11939689)
1. Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis.
Cawley MJ; Suh C; Lee S; Ackerman BH
Pharmacotherapy; 2002 Apr; 22(4):527-32. PubMed ID: 11939689
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam.
Jiménez-Mejías ME; Pachón J; Becerril B; Palomino-Nicás J; Rodríguez-Cobacho A; Revuelta M
Clin Infect Dis; 1997 May; 24(5):932-5. PubMed ID: 9142795
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of multidrug-resistant
Sun L; Wang X; Li Z
Br J Neurosurg; 2018 Dec; 32(6):642-645. PubMed ID: 28431478
[No Abstract] [Full Text] [Related]
4. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical and microbiological efficacy of antibiotic regimens against Acinetobacter baumannii.
Ackerman BH; Haith LR; Patton ML; Guilday RE; Reigart CL; Stair-Buchmann M
J Burn Care Res; 2013; 34(4):403-12. PubMed ID: 23237825
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam.
Jellison TK; Mckinnon PS; Rybak MJ
Pharmacotherapy; 2001 Feb; 21(2):142-8. PubMed ID: 11213849
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.
Corbella X; Ariza J; Ardanuy C; Vuelta M; Tubau F; Sora M; Pujol M; Gudiol F
J Antimicrob Chemother; 1998 Dec; 42(6):793-802. PubMed ID: 10052904
[TBL] [Abstract][Full Text] [Related]
8. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Levin AS; Levy CE; Manrique AE; Medeiros EA; Costa SF
Int J Antimicrob Agents; 2003 Jan; 21(1):58-62. PubMed ID: 12507838
[TBL] [Abstract][Full Text] [Related]
9. Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Kendirli T; Aydín HI; Hacíhamdioğlu D; Gülgün M; Unay B; Akín R; Lenk MK; Gökçay E
J Hosp Infect; 2004 Apr; 56(4):328. PubMed ID: 15066747
[No Abstract] [Full Text] [Related]
10. Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients.
Horianopoulou M; Kanellopoulou M; Paraskevopoulos I; Kyriakidis A; Legakis NJ; Lambropoulos S
Clin Microbiol Infect; 2004 Jan; 10(1):85-6. PubMed ID: 14706094
[No Abstract] [Full Text] [Related]
11. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F
Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.
Smolyakov R; Borer A; Riesenberg K; Schlaeffer F; Alkan M; Porath A; Rimar D; Almog Y; Gilad J
J Hosp Infect; 2003 May; 54(1):32-8. PubMed ID: 12767844
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Kuo LC; Lai CC; Liao CH; Hsu CK; Chang YL; Chang CY; Hsueh PR
Clin Microbiol Infect; 2007 Feb; 13(2):196-198. PubMed ID: 17328733
[TBL] [Abstract][Full Text] [Related]
17. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
Betrosian AP; Frantzeskaki F; Xanthaki A; Georgiadis G
Scand J Infect Dis; 2007; 39(1):38-43. PubMed ID: 17366011
[TBL] [Abstract][Full Text] [Related]
18. Extensively-drug resistant
Gkentzi D; Tsintoni A; Christopoulou I; Mamalis I; Paliogianni F; Assimakopoulos SF; Marangos M; Dimitriou G
J Chemother; 2020 Apr; 32(2):103-106. PubMed ID: 31992156
[No Abstract] [Full Text] [Related]
19. Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin.
Mellon G; Clec'h C; Picard B; Cohen Y; Jauréguy F
J Infect Chemother; 2012 Dec; 18(6):958-60. PubMed ID: 22430257
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.
Lee CH; Tang YF; Su LH; Chien CC; Liu JW
Microb Drug Resist; 2008 Sep; 14(3):233-7. PubMed ID: 18707240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
